ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or the "Company"), a pioneer in thermoacoustic biomarker imaging for the ...
Adding MRI to CT may improve the accuracy of detecting nonviable disappearing liver metastases than CT alone among patients with initially unresectable colorectal liver metastases. However, confirmed ...
Full-body MRIs are all the rage. We take a look at three major companies offering such testing.
Ultrasound is currently the standard imaging tool for HCC surveillance. However, prior evidence has suggested that contrast-enhanced MRI—particularly with gadoxetate disodium—may detect tumors more ...
Hepatocellular carcinoma (HCC) remains a primary cause of cancer-related mortality, particularly for individuals living with cirrhosis or chronic hepatitis B. While many expert associations recommend ...
Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring ENDRA Life Sciences Inc ...
An advantage of whole-body MRIs over CTs is that they use magnets and radio waves, which eliminate the type of radiation linked to cancer. But that doesn’t mean they’re risk-free or the right choice ...